309 related articles for article (PubMed ID: 23492819)
1. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.
Singh B; Ronghe AM; Chatterjee A; Bhat NK; Bhat HK
Carcinogenesis; 2013 May; 34(5):1165-72. PubMed ID: 23492819
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.
Singh B; Shoulson R; Chatterjee A; Ronghe A; Bhat NK; Dim DC; Bhat HK
Carcinogenesis; 2014 Aug; 35(8):1872-80. PubMed ID: 24894866
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-153 Regulates NRF2 Expression and is Associated with Breast Carcinogenesis.
Wang B; Teng Y; Liu Q
Clin Lab; 2016; 62(1-2):39-47. PubMed ID: 27012032
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention.
Munagala R; Aqil F; Vadhanam MV; Gupta RC
Cancer Lett; 2013 Oct; 339(2):175-84. PubMed ID: 23791885
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer.
Singh B; Chatterjee A; Ronghe AM; Bhat NK; Bhat HK
BMC Cancer; 2013 May; 13():253. PubMed ID: 23697596
[TBL] [Abstract][Full Text] [Related]
6. Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer.
Singh B; Bhat HK
Carcinogenesis; 2012 Dec; 33(12):2601-10. PubMed ID: 23027624
[TBL] [Abstract][Full Text] [Related]
7. Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.
Singh B; Bhat NK; Bhat HK
Carcinogenesis; 2012 Jan; 33(1):156-63. PubMed ID: 22072621
[TBL] [Abstract][Full Text] [Related]
8. miR-140-5p Attenuates Hypoxia-Induced Breast Cancer Progression by Targeting Nrf2/HO-1 Axis in a Keap1-Independent Mechanism.
Mahajan M; Sitasawad S
Cells; 2021 Dec; 11(1):. PubMed ID: 35011574
[TBL] [Abstract][Full Text] [Related]
9. Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.
Mense SM; Singh B; Remotti F; Liu X; Bhat HK
Carcinogenesis; 2009 Jul; 30(7):1202-8. PubMed ID: 19406931
[TBL] [Abstract][Full Text] [Related]
10. Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia.
Smolarek AK; So JY; Thomas PE; Lee HJ; Paul S; Dombrowski A; Wang CX; Saw CL; Khor TO; Kong AN; Reuhl K; Lee MJ; Yang CS; Suh N
Mol Carcinog; 2013 Jul; 52(7):514-25. PubMed ID: 22389237
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-155 regulates arsenite-induced malignant transformation by targeting Nrf2-mediated oxidative damage in human bronchial epithelial cells.
Chen C; Jiang X; Gu S; Zhang Z
Toxicol Lett; 2017 Aug; 278():38-47. PubMed ID: 28688901
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation.
Zhou X; Zhao Y; Wang J; Wang X; Chen C; Yin D; Zhao F; Yin J; Guo M; Zhang L; Du L; Zhang B; Yin X
Biochem Pharmacol; 2018 Sep; 155():252-263. PubMed ID: 30009768
[TBL] [Abstract][Full Text] [Related]
13. 4-Hydroxyestradiol induces mammary epithelial cell transformation through Nrf2-mediated heme oxygenase-1 overexpression.
Park SA; Lee MH; Na HK; Surh YJ
Oncotarget; 2017 Jan; 8(1):164-178. PubMed ID: 27438141
[TBL] [Abstract][Full Text] [Related]
14. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.
Eades G; Yang M; Yao Y; Zhang Y; Zhou Q
J Biol Chem; 2011 Nov; 286(47):40725-33. PubMed ID: 21926171
[TBL] [Abstract][Full Text] [Related]
15. An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma.
Masuda M; Miki Y; Hata S; Takagi K; Sakurai M; Ono K; Suzuki K; Yang Y; Abe E; Hirakawa H; Ishida T; Suzuki T; Ohuchi N; Sasano H
J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S2. PubMed ID: 23227519
[TBL] [Abstract][Full Text] [Related]
16. 17β-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner.
Fang D; Yang H; Lin J; Teng Y; Jiang Y; Chen J; Li Y
Biochem Biophys Res Commun; 2015 Feb; 457(4):500-6. PubMed ID: 25592968
[TBL] [Abstract][Full Text] [Related]
17. Carcinogenic potential of fluorinated estrogens in mammary tumorigenesis.
Okamoto Y; Jinno H; Itoh S; Shibutani S
Toxicol Lett; 2020 Jan; 318():99-103. PubMed ID: 31669098
[TBL] [Abstract][Full Text] [Related]
18. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism.
Yang M; Yao Y; Eades G; Zhang Y; Zhou Q
Breast Cancer Res Treat; 2011 Oct; 129(3):983-91. PubMed ID: 21638050
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cells.
Son YO; Pratheeshkumar P; Divya SP; Zhang Z; Shi X
J Biol Chem; 2017 May; 292(20):8315-8330. PubMed ID: 28330870
[TBL] [Abstract][Full Text] [Related]
20. Baicalein has protective effects on the 17β-estradiol-induced transformation of breast epithelial cells.
Chen Y; Wang J; Hong DY; Chen L; Zhang YY; Xu YN; Pan D; Fu LY; Tao L; Luo H; Shen XC
Oncotarget; 2017 Feb; 8(6):10470-10484. PubMed ID: 28060756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]